Patents by Inventor Motonori Miyakawa

Motonori Miyakawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thyronamine derivatives and analogs and methods of use thereof
    Patent number: 7355079
    Abstract: Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
    Type: Grant
    Filed: April 5, 2005
    Date of Patent: April 8, 2008
    Assignees: The Regents of the University of California, Oregon Health & Science University
    Inventors: Thomas S. Scanlan, Matthew E. Hart, David K. Grandy, James R. Bunzow, Motonori Miyakawa, Edwin Saavedra Tan, Katherine L. Suchland
  • Thyronamine derivatives and analogs and methods of use thereof
    Patent number: 7321065
    Abstract: Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: January 22, 2008
    Assignees: The Regents of the University of California, Oregon Health & Science University
    Inventors: Thomas S. Scanlan, Matthew E. Hart, David K. Grandy, James R. Bunzow, Motonori Miyakawa, Edwin Saavedra Tan, Katherine L. Suchland
  • Androgen receptor agonists
    Publication number: 20060128737
    Abstract: The present invention provides nonsteroidal tetrahydroquinoline derivatives of general formula (I) or salts thereof: (R1, R2, X, Y, Z and m are as defined in claim 1) which show no excessive action on the prostate but show a particularly potent androgen receptor agonistic action on skeletal muscle tissue and bone tissue, as well as pharmaceuticals comprising such derivatives or their salts as active ingredients.
    Type: Application
    Filed: June 19, 2003
    Publication date: June 15, 2006
    Applicant: KAKEN PHARMACEUTICAL CO., LTD.
    Inventors: Motonori Miyakawa, Yuji Sumita, Kazuyuki Furuya, Kiyonoshin Ichikawa, Noriko Yamamoto, Seiji Amano, Hiroaki Nejishima, Keigo Hanada
  • Tetrahydroquinoline derivatives
    Patent number: 7037919
    Abstract: Tetrahydroquinoline derivatives of general formula (I) or salts thereof, having a specific and strong binding affinity for AR and exhibiting AR agonism or antagonism; and pharmaceutical compositions containing the derivatives or the salts.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: May 2, 2006
    Assignee: Kaken Pharmaceutical Co. Ltd.
    Inventors: Keigo Hanada, Kazuyuki Furuya, Kiyoshi Inoguchi, Motonori Miyakawa, Naoya Nagata
  • Thyronamine derivatives and analogs and methods of use thereof
    Publication number: 20060035980
    Abstract: Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
    Type: Application
    Filed: April 5, 2005
    Publication date: February 16, 2006
    Inventors: Thomas Scanlan, Matthew Hart, David Grandy, James Bunzow, Motonori Miyakawa, Edwin Tan, Katherine Suchland
  • Novel tetrahydroquinoline derivatives
    Publication number: 20050277660
    Abstract: The present invention provides tetrahydroquinoline derivatives of the following general formula (I) or salts thereof where R1, R2, X, Y and i are as defined in claim 1, which do not exhibit excessive action on the prostate, but which exhibit strong androgen receptor agonistic action particularly on skeletal muscle tissue and bone tissue, and pharmaceuticals comprising such derivatives or their salts as active ingredients.
    Type: Application
    Filed: August 1, 2003
    Publication date: December 15, 2005
    Inventor: Motonori Miyakawa
  • Tetrahydroquinoline compounds
    Patent number: 6777427
    Abstract: Tetrahydroquinoline compounds of general formula (I) or pharmacologically acceptable salts thereof, which have a specific and strong binding affinity for AR, exhibit AR agonism or antagonism, have therapeutic effects on AR-mediated diseases, particularly by not acting excessively on the prostate as AR agonists, but by showing potent action on skeletal muscle tissue and bone tissue; and pharmaceutical compositions comprising the compounds or the salts as active ingredients:
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: August 17, 2004
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Motonori Miyakawa, Seiji Amano, Misa Kamei, Keigo Hanada, Kazuyuki Furuya, Noriko Yamamoto
  • Tetrahydroquinoline compounds
    Publication number: 20030216428
    Abstract: Tetrahydroquinoline compounds of general formula (I) or pharmacologically acceptable salts thereof, which have a specific and strong binding affinity for AR, exhibit AR agonism or antagonism, have therapeutic effects on AR-mediated diseases, particularly by not acting excessively on the prostate as AR agonists, but by showing potent action on skeletal muscle tissue and bone tissue; and pharmaceutical compositions comprising the compounds or the salts as active ingredients: 1
    Type: Application
    Filed: March 13, 2003
    Publication date: November 20, 2003
    Inventors: Motonori Miyakawa, Seiji Amano, Misa Kamei, Keigo Hanada, Kazuyuki Furuya, Noriko Yamamoto